Indivior Pharmaceuticals, Inc. (INDV)
31.49
-1.03
(-3.17%)
USD |
NASDAQ |
Apr 16, 16:00
31.49
0.00 (0.00%)
After-Hours: 20:00
Indivior Pharmaceuticals Research and Development Expense (Quarterly) : 17.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 12.26M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Liquidia Corp. | 16.72M |
| Pulse Biosciences, Inc. | 10.93M |
| Ultragenyx Pharmaceutical, Inc. | 194.22M |